Search Results - F. Lansigan

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    P1156: MAGNIFY PHASE 3B STUDY OF LENALIDOMIDE + RITUXIMAB (R2) FOLLOWED BY MAINTENANCE IN RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA: COMPLETE INDUCTION PHASE ANALYSIS by F. Lansigan, D. J. Andorsky, M. Coleman, A. Yacoub, J. M. Melear, S. R. Fanning, K. S. Kolibaba, C. Reynolds, G. S. Nowakowski, M. Gharibo, J. R. Ahn, J. Li, M. J. Rummel, J. P. Sharman

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    P675: TREATMENT OF HYPERTENSION IN PATIENTS RECEIVING BTK INHIBITORS: A MULTICENTER RETROSPECTIVE STUDY by M. Shadman, J. Voutsinas, B. Fakhri, S. Khajavian, S. Spurgeon, D. Stephens, A. Skarnbik, A. Mato, C. Broome, A. Gopal, S. Smith, R. Lynch, M. Rainey, S. Kim, O. Barrett-Campbell, E. Hemond, M. Tsang, D. Ermann, N. Malakhov, D. Rao, M. Shakib Azar, B. Morrigan, A. Chauhan, T. Plate, T. Gooley, K. Ryan, F. Lansigan, B. Hill, G. Pongas, S. Parikh, L. Roeker, J. Allan, R. Cheng, C. Ujjani

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  3. 3

    P671: TREATMENT SEQUENCES AND OUTCOMES OF PATIENTS WITH CLL TREATED WITH TARGETED AGENTS IN REAL-WORLD SETTINGS by A. R. Mato, B. S. Manzoor, C. C. Coombs, N. Lamanna, H. H. Tuncer, J. R. Brown, L. E. Roeker, M. Shadman, J. N. Allan, C. Ujjani, B. Eichhorst, L. Leslie, I. Fleury, H. Alhasani, J. Rhodes, B. T. Hill, P. M. Barr, A. Skarbnik, M. S. Davids, R. Bannerji, M. Fuldeore, F. Lansigan, A. Schuh, L. Pearson, C. P. Fox, I. Pivneva, L. Popadic, A. Guerin, T. A. Eyre

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: